Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 4
2009 3
2010 5
2011 5
2012 5
2014 5
2015 8
2016 3
2017 3
2018 6
2019 14
2020 22
2021 21
2022 23
2023 21
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel.
Raje N, Anderson K, Einsele H, Efebera Y, Gay F, Hammond SP, Lesokhin AM, Lonial S, Ludwig H, Moreau P, Patel K, Ramasamy K, Mateos MV. Raje N, et al. Among authors: ramasamy k. Blood Cancer J. 2023 Aug 1;13(1):116. doi: 10.1038/s41408-023-00879-7. Blood Cancer J. 2023. PMID: 37528088 Free PMC article. Review.
Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma.
Dimopoulos MA, Jakubowiak AJ, McCarthy PL, Orlowski RZ, Attal M, Bladé J, Goldschmidt H, Weisel KC, Ramasamy K, Zweegman S, Spencer A, Huang JSY, Lu J, Sunami K, Iida S, Chng WJ, Holstein SA, Rocci A, Skacel T, Labotka R, Palumbo A, Anderson KC. Dimopoulos MA, et al. Among authors: ramasamy k. Blood Cancer J. 2020 Feb 13;10(2):17. doi: 10.1038/s41408-020-0273-x. Blood Cancer J. 2020. PMID: 32054831 Free PMC article. Review.
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.
Richardson PG, Trudel S, Popat R, Mateos MV, Vangsted AJ, Ramasamy K, Martinez-Lopez J, Quach H, Orlowski RZ, Arnao M, Lonial S, Karanes C, Pawlyn C, Kim K, Oriol A, Berdeja JG, Rodríguez Otero P, Casas-Avilés I, Spirli A, Poon J, Li S, Gong J, Wong L, Lamba M, Pierce DW, Amatangelo M, Peluso T, Maciag P, Katz J, Pourdehnad M, Bahlis NJ; CC-92480-MM-001 Study Investigators. Richardson PG, et al. Among authors: ramasamy k. N Engl J Med. 2023 Sep 14;389(11):1009-1022. doi: 10.1056/NEJMoa2303194. Epub 2023 Aug 30. N Engl J Med. 2023. PMID: 37646702 Clinical Trial.
Myoepithelioma.
Karthik RS, Sivakumar JS, Cholan R, Shanmugapriya, Rajan VS, Moorthy MS, Yamunadevi A, Karthik BV. Karthik RS, et al. J Pharm Bioallied Sci. 2015 Aug;7(Suppl 2):S779-81. doi: 10.4103/0975-7406.163560. J Pharm Bioallied Sci. 2015. PMID: 26538968 Free PMC article.
Flicking the switch in myeloma MRD.
Watson E, Ramasamy K. Watson E, et al. Among authors: ramasamy k. Blood. 2023 Feb 9;141(6):557-558. doi: 10.1182/blood.2022018394. Blood. 2023. PMID: 36757729 Free article. No abstract available.
Editorial: T-cell directed therapies in multiple myeloma.
Richter J, Anderson LD Jr, Ramasamy K, Rossi A. Richter J, et al. Among authors: ramasamy k. Front Oncol. 2023 Jun 16;13:1206475. doi: 10.3389/fonc.2023.1206475. eCollection 2023. Front Oncol. 2023. PMID: 37397395 Free PMC article. No abstract available.
Time to redefine Myeloma.
Pratt G, Bowcock S, Chantry A, Cook G, Jackson G, Lai M, Low E, Mulholland N, Owen R, Rabin N, Ramasamy K, Snowden JA, Streetly M, Wechalekar A, Yong K, Bird J. Pratt G, et al. Among authors: ramasamy k. Br J Haematol. 2015 Oct;171(1):1-10. doi: 10.1111/bjh.13620. Epub 2015 Jul 27. Br J Haematol. 2015. PMID: 26221971 Free article.
Management of patients with difficult-to-treat multiple myeloma.
Richter J, Ramasamy K, Rasche L, Bladé J, Zweegman S, Davies F, Dimopoulos M. Richter J, et al. Among authors: ramasamy k. Future Oncol. 2021 Jun;17(16):2089-2105. doi: 10.2217/fon-2020-1280. Epub 2021 Mar 12. Future Oncol. 2021. PMID: 33706558 Review.
The management of Castleman disease.
Lomas OC, Streetly M, Pratt G, Cavet J, Royston D, Schey S, Ramasamy K; British Society for Haematology (BSH) Committee. Lomas OC, et al. Among authors: ramasamy k. Br J Haematol. 2021 Nov;195(3):328-337. doi: 10.1111/bjh.17688. Epub 2021 Aug 2. Br J Haematol. 2021. PMID: 34340261 No abstract available.
140 results